Articles tagged with: B Cell
News»

In a recent multi-center study, Spanish researchers identified several immune system characteristics of multiple myeloma patients who have achieved long-term disease control.
They found that patients who achieve long-term disease control have a distinct immune system profile that differs from patients with active disease and from that of healthy adults.
This distinct profile, the researchers argue, likely plays a role in the patients achieving long-term control of their myeloma, and thus deserves further investigation.
The majority of multiple myeloma patients relapse within a median of three years from their initial diagnosis. However, …